$1.0K
Revenue
1.0K
Downloads
N/A
Rating
Screenshots
How Much Does Urothelkarzinom onkowissen Make?
Monthly Revenue
$1.0K
Yearly Revenue
$12.0K
Per Download
$1.00
Platform Performance
🍎iOS
Revenue
$1.0K
Downloads
1.0K
Rating Distribution
N/A
☆☆☆☆☆
0 reviews
No rating data available
Top Countries
🇩🇪 DE🇨🇭 CH🇺🇦 UA
Version History (8)▼
1.79/24/2025
1.610/21/2024
1.56/24/2024
1.43/9/2023
1.31/12/2023
1.26/1/2022
1.14/29/2022
1.06/21/2021
Available In (115 Countries)▼
🇺🇸 United States🇦🇺 Australia🇨🇦 Canada🇨🇳 China🇫🇷 France🇩🇪 Germany🇬🇧 United Kingdom🇮🇹 Italy🇯🇵 Japan🇰🇷 South Korea🇷🇺 Russia🇩🇿 DZ🇦🇴 AO🇦🇷 Argentina🇦🇹 Austria🇦🇿 AZ🇧🇭 BH🇧🇧 BB🇧🇾 BY🇧🇪 Belgium🇧🇲 BM🇧🇷 Brazil🇧🇬 Bulgaria🇨🇱 Chile🇨🇴 Colombia🇨🇷 CR🇭🇷 Croatia🇨🇾 CY🇨🇿 Czech Republic🇩🇰 Denmark🇩🇴 DO🇪🇨 EC🇪🇬 Egypt🇸🇻 SV🇫🇮 Finland🇬🇭 GH🇬🇷 Greece🇬🇹 GT🇭🇰 Hong Kong🇭🇺 Hungary🇮🇳 India🇮🇩 Indonesia🇮🇪 Ireland🇮🇱 Israel🇰🇿 KZ🇰🇪 Kenya🇰🇼 KW🇱🇧 LB🇱🇹 Lithuania🇱🇺 LU🇲🇴 MO🇲🇬 MG🇲🇾 Malaysia🇲🇹 MT🇲🇽 Mexico🇳🇱 Netherlands🇳🇿 New Zealand🇳🇬 Nigeria🇳🇴 Norway🇴🇲 OM🇵🇰 Pakistan🇵🇦 PA🇵🇪 Peru🇵🇭 Philippines🇵🇱 Poland🇵🇹 Portugal🇶🇦 QA🇷🇴 Romania🇸🇦 Saudi Arabia🇷🇸 RS🇸🇬 Singapore🇸🇰 Slovakia🇸🇮 Slovenia🇿🇦 South Africa🇪🇸 Spain🇱🇰 LK🇸🇪 Sweden🇨🇭 Switzerland🇹🇼 Taiwan🇹🇭 Thailand🇹🇳 TN🇹🇷 Turkey🇺🇦 Ukraine🇦🇪 UAE🇺🇾 UY🇺🇿 UZ🇻🇪 VE🇻🇳 Vietnam🇧🇴 BO🇰🇭 KH🇪🇪 Estonia🇱🇻 Latvia🇳🇮 NI🇵🇾 PY🇦🇫 AF🇬🇪 GE🇮🇶 IQ🇱🇾 LY🇲🇦 MA🇲🇿 MZ🇲🇲 MM🇾🇪 YE🇧🇯 BJ🇧🇫 BF🇨🇲 CM🇨🇬 CG🇨🇮 CI🇯🇴 JO🇱🇦 LA🇲🇱 ML🇸🇳 SN🇹🇿 TZ🇺🇬 UG🇿🇲 ZM🇿🇼 ZW
Supported Languages (1)▼
German
App Details▼
Die App "onkowissen Urothelkarzinom": schnell, smart, mobil – evidenzbasiertes Onkologiewissen Die App onkowissen Urothelkarzinom bietet Ihnen einen...
Publisher
onkowissen.de GmbH
Similar Apps
INKA
Dr. Pfleger Arzneimittel GmbH
Leitlinienprogramm Onkologie
Deutsche Krebsgesellschaft e.V.
Onkopedia Leitlinienportal
DGHO
Antiinfektiva Leitfaden
TUM Klinikum Rechts der Isar Technische Universitaet Muenchen
EasyOncology
Onqo Health GmbH
Uroletics
Rocketlane Medical Ventures GmbH
DGU 2024
Deutsche Gesellschaft fur Urologie e.V.
PraxisApp - Urologie
Monks
Dt. Gesellschaft für Urologie
Deutsche Gesellschaft fur Urologie e.V.
Oncologics
ClinSol Research GmbH